Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Current Leases (2019 - 2025)

IDEAYA Biosciences (IDYA) has disclosed Current Leases for 7 consecutive years, with $339000.0 as the latest value for Q4 2025.

  • Quarterly Current Leases rose 13.76% to $339000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $339000.0 through Dec 2025, up 13.76% year-over-year, with the annual reading at $339000.0 for FY2025, 13.76% up from the prior year.
  • Current Leases hit $339000.0 in Q4 2025 for IDEAYA Biosciences, up from $328000.0 in the prior quarter.
  • In the past five years, Current Leases ranged from a high of $2.1 million in Q3 2023 to a low of $298000.0 in Q4 2024.
  • Historically, Current Leases has averaged $1.3 million across 5 years, with a median of $1.7 million in 2021.
  • Biggest five-year swings in Current Leases: surged 34.18% in 2021 and later plummeted 82.94% in 2024.
  • Year by year, Current Leases stood at $1.7 million in 2021, then increased by 10.12% to $1.9 million in 2022, then dropped by 6.63% to $1.7 million in 2023, then tumbled by 82.94% to $298000.0 in 2024, then rose by 13.76% to $339000.0 in 2025.
  • Business Quant data shows Current Leases for IDYA at $339000.0 in Q4 2025, $328000.0 in Q3 2025, and $318000.0 in Q2 2025.